Longitudinal evaluation of pulmonary function tests in children with newborn screening for cystic fibrosis. Relationships with pulmonary infection. Study of 40 children undergoing 744 pulmonary function tests;Évolution des épreuves fonctionnelles respiratoires (EFR) chez des enfants atteints de mucoviscidose et dépistés à la naissance. Lien avec l'infection pulmonaire. Étude sur 40 enfants et 744 EFR

Archives de Pediatrie

Volumn 14, Issue 7, 2007, Pages 864-869

  Burggraeve, N ^a   Branger, B ^b   Dabadie, A ^a   Deneuville, E ^a   Rault, G ^c   Roussey, M ^a  

^a RENNES UNIVERSITY HOSPITAL   (France)

^b Reseau Securite Naissance Naitre Ensemble des Pays de la Loire   (France)

^c Centre Helio Marin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENOTYPE; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION TEST; LUNG INFECTION; MALE; MICROBIOLOGICAL EXAMINATION; NEWBORN SCREENING; NUTRITIONAL STATUS; PSEUDOMONAS AERUGINOSA; SEX DIFFERENCE; BACTERIAL PNEUMONIA; FOLLOW UP; GRAM NEGATIVE INFECTION; INFANT; LUNG VENTILATION; NEWBORN; PATHOPHYSIOLOGY; PEAK EXPIRATORY FLOW; PRESCHOOL CHILD; VITAL CAPACITY;

CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MAXIMAL EXPIRATORY FLOW RATE; MAXIMAL VOLUNTARY VENTILATION; NEONATAL SCREENING; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; RESPIRATORY FUNCTION TESTS; VITAL CAPACITY;

EID: 34250876851     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2007.02.089     Document Type: Article

References (26)

1. Bush A. Decisions facing the cystic fibrosis clinician at first isolation of Pseudomonas aeruginosa. Paediatr. Respir. Rev. 3 (2002) 82-88
2. Doring G., Conway S.P., Heijerman H.G., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: an European consensus. Eur. Respir. J. 16 (2000) 749-767
3. Gibson R.L., Burns J.L., and Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168 (2003) 918-951
4. Demko C.A., Byard P.J., and Davis P.B. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J. Clin. Epidemiol. 48 (1995) 1041-1049
5. Pamukcu A., Bush A., and Buchdahl R. Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr. Pulmonol. 19 (1995) 10-15
6. Kosorok M.R., Zeng L., West S.E., et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr. Pulmonol. 32 (2001) 277-287
7. Schaedel C., de Monestrol I., Hjelte L., et al. Predictors of deterioration of lung function in cystic fibrosis. Pediatr. Pulmonol. 33 (2002) 483-491
8. Parad R.B., Gerard C.J., Zurakowski D., et al. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect. Immun. 67 (1999) 4744-4750
9. Li Z., Kosorok M.R., Farrell P.M., et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 293 (2005) 581-588
10. Emerson J., Rosenfeld M., McNamara S., et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr. Pulmonol. 34 (2002) 91-100
11. Ramsey B.W., and Boat T.F. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J. Pediatr. 124 (1994) 177-192
12. Mastella G., Hodson M.E., Koch C., et al. Factors affecting velocity of lung function deterioration in ERCF cystic fibrosis patients over 2-4 years follow-up. Neth. J. Med. 54 Suppl (1999) S22
13. Saiman L., and Edwards L. Cystic Fibrosis Conference. Symposium session summaries 15 3 (1999) 147-148
14. Burns J.L., Emerson J., Stapp J.R., et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27 (1998) 158-163
15. Feldmann D. Mucoviscidose : un dépistage pour toute la France. Ann. Biol. Clin. (Paris) 60 (2002) 693-695
16. Kerem E., Corey M., Gold R., et al. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J. Pediatr. 116 (1990) 714-719
17. Corey M., Edwards L., Levison H., et al. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J. Pediatr. 131 (1997) 809-814
18. Crapo R.O. Pulmonary-function testing. N. Engl. J. Med. 331 (1994) 25-30
19. Hoiby N., Frederiksen B., and Pressler T. Eradication of early Pseudomonas aeruginosa infection. J. Cyst. Fibros. 4 Suppl 2 (2005) 49-54
20. Zemel B.S., Jawad A.F., FitzSimmons S., et al. Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J. Pediatr. 137 (2000) 374-380
21. de Gracia J., Mata F., Alvarez A., et al. Genotype-phenotype correlation for pulmonary function in cystic fibrosis. Thorax 60 (2005) 558-563
22. Steinkamp G., and Wiedemann B. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 57 (2002) 596-601
23. Peterson M.L., Jacobs Jr. D.R., and Milla C.E. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics 112 (2003) 588-592
24. Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. J. Pediatr. 147 (2005) S11-S14
25. Rosenfeld M., Davis R., FitzSimmons S., et al. Gender gap in cystic fibrosis mortality. Am. J. Epidemiol. 145 (1997) 794-803
26. Schneiderman-Walker J., Wilkes D.L., Strug L., et al. Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. J. Pediatr. 147 (2005) 321-326